Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 27;6(9):ofz302.
doi: 10.1093/ofid/ofz302. eCollection 2019 Sep.

Blurred Molecular Epidemiological Lines Between the Two Dominant Methicillin-Resistant Staphylococcus aureus Clones

Affiliations

Blurred Molecular Epidemiological Lines Between the Two Dominant Methicillin-Resistant Staphylococcus aureus Clones

Amy C Dupper et al. Open Forum Infect Dis. .

Abstract

Background: Methicillin-resistant Staphylococcus aureus (MRSA) causes life-threatening infections in both community and hospital settings and is a leading cause of health care-associated infections (HAIs). We sought to describe the molecular epidemiological landscape of patients with MRSA bloodstream infections (BSIs) at an urban medical center by evaluating the clinical characteristics associated with the two dominant endemic clones.

Methods: Comprehensive clinical data from the electronic health records of 227 hospitalized patients ≥18 years old with MRSA BSI over a 33-month period in New York City were collected. The descriptive epidemiology and mortality associated with the two dominant clones were compared using logistic regression.

Results: Molecular analysis revealed that 91% of all single-patient MRSA BSIs were due to two equally represented genotypes, clonal complex (CC) 5 (n = 117) and CC8 (n = 110). MRSA BSIs were associated with a 90-day mortality rate of 27%. CC8 caused disease more frequently in younger age groups (56 ± 17 vs 67 ± 17 years old; P < .001) and in those of nonwhite race (odds ratio [OR], 3.45; 95% confidence interval [CI], 1.51-7.87; P = .003), with few other major distinguishing features. Morbidity and mortality also did not differ significantly between the two clones. CC8 caused BSIs more frequently in the setting of peripheral intravenous catheters (OR, 5.96; 95% CI, 1.51-23.50; P = .01).

Conclusions: The clinical features distinguishing dominant MRSA clones continue to converge. The association of CC8 with peripheral intravenous catheter infections underscores the importance of classical community clones causing hospital-onset infections. Ongoing monitoring and analysis of the dynamic epidemiology of this endemic pathogen are crucial to inform management and prevent disease.

Keywords: bloodstream infections; methicillin-resistant Staphylococcus aureus; molecular epidemiology; peripheral intravenous catheters.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Core genome multilocus sequence typing (cgMLST) of methicillin-resistant Staphylococcus aureus bloodstream infection isolates under study. Clustering of isolates into clonal complex (CC) 5 and CC8, as well as USA300 and USA500, was based on cgMLST data. Ridom spa types are listed on the right. The arrows point to the published NCBI reference genomes for each grouping. “Unknown” refers to a spa type not listed in the Ridom database.

References

    1. Kallen AJ, Mu Y, Bulens S, et al. . Health care-associated invasive MRSA infections, 2005–2008. JAMA 2010; 304:641–8. - PubMed
    1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520–32. - PubMed
    1. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629–41. - PMC - PubMed
    1. Klevens RM, Morrison MA, Nadle J, et al. . Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763–71. - PubMed
    1. McHugh CG, Riley LW. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 2004; 25:425–30. - PubMed